Physician profile
Chester Ching
NPI 1568481281
$1,069.57
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4.18 · 2021: $186 · 2022: $21.21 · 2023: $80.45 · 2024: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $309.94 | 2021-2024 | |
| Amgen INC. | $229.41 | 2023-2024 | Tavneos, Parsabiv, Aranesp |
| Travere Therapeutics, INC. | $133.29 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $125.00 | 2024 | Acthar |
| Ardelyx, INC. | $124.40 | 2024 | Xphozah 30 Mg |
| Nxstage Medical, INC. | $82.10 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.07 | 2024 | Jardiance |
| Aurinia Pharma U.S., INC. | $21.21 | 2022 | |
| Vifor Pharma, INC. | $15.15 | 2023 | Korsuva, Veltassa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chester Ching listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.